Transarterial chemoembolization aggravated peritumoral fibrosis via hypoxia-inducible factor-1α dependent pathway in hepatocellular carcinoma

Background and Aim It was commonly accepted that chemotherapeutic cytotoxicity was the main cause for hepatic failure in hepatocellular carcinoma patients after repeated transarterial chemoembolization (TACE). However, the effect of embolization‐induced hypoxia on liver cirrhosis has rarely been con...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of gastroenterology and hepatology 2015-05, Vol.30 (5), p.925-932
Hauptverfasser: Qu, Kai, Yan, Zhaoyong, Wu, Yousheng, Chen, Yibing, Qu, Ping, Xu, Xinsen, Yuan, Peng, Huang, Xiaojun, Xing, Jinliang, Zhang, Hongxin, Liu, Chang, Zhang, Jing
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 932
container_issue 5
container_start_page 925
container_title Journal of gastroenterology and hepatology
container_volume 30
creator Qu, Kai
Yan, Zhaoyong
Wu, Yousheng
Chen, Yibing
Qu, Ping
Xu, Xinsen
Yuan, Peng
Huang, Xiaojun
Xing, Jinliang
Zhang, Hongxin
Liu, Chang
Zhang, Jing
description Background and Aim It was commonly accepted that chemotherapeutic cytotoxicity was the main cause for hepatic failure in hepatocellular carcinoma patients after repeated transarterial chemoembolization (TACE). However, the effect of embolization‐induced hypoxia on liver cirrhosis has rarely been concerned. Methods Serum levels of alanine aminotransferase, aspartate aminotransferase, and albumin were used to detect liver injury. Hepatic artery ligation was performed in carbon tetrachloride‐induced rat hepatic fibrosis model to mimic the effect of hepatic hypoxia on liver fibrosis after TACE. Sirius Red staining and immunohistochemical analysis of alpha‐smooth muscle actin (α‐SMA) were used to detect the activation of hepatic stellate cells. Moreover, the expression of hypoxia and fibrosis‐related molecules were analyzed at protein and/or mRNA level. Results Patients showed a significant increase in alanine aminotransferase and aspartate aminotransferase (P = 0.006), accompanied by a decrease in albumin (P = 0.005) after repeated TACE. Hepatic artery ligation significantly promoted carbon tetrachloride‐induced rat liver fibrosis progression as indicated by Sirius Red and α‐SMA staining, as well as increased expression of hypoxia‐inducible factor (HIF)‐1α, transforming growth factor (TGF)‐β1, and vascular endothelial growth factor (VEGF). Conditioned media of hypoxia‐treated L02 cells induced the expression of Collagen I and α‐SMA in LX‐2 cells, which was inhibited by HIF‐1α small interfering RNA. Finally, HIF‐1α inhibitor LW6 attenuated the hypoxia‐induced fibrosis progression in vivo. Conclusion Our data demonstrate that TACE‐induced hepatic hypoxia aggravates the fibrosis progression in peritumoral liver tissue, thus leads to the deterioration of liver function. Intervention of HIF‐1α might be a valuable strategy to optimize the efficacy and reduce the complication of TACE.
doi_str_mv 10.1111/jgh.12873
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1673074857</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1673074857</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3633-60a855b82e625567e3ced00d267cb1818ae6e1ae5c9fe5388b52c2402f000a873</originalsourceid><addsrcrecordid>eNp1kMFu1DAQhi0EokvhwAsgH-GQ1o5jO3uEquxCq3Ip6tGaOJONSxIHO2m7PATvwovwTHi7bW_MZTTSN79mPkLecnbEUx1fb9ojnpdaPCMLXhQs47pQz8mClVxmS8GXB-RVjNeMsYJp-ZIc5FIVXGi9IL8vAwwRwoTBQUdti73HvvKd-wWT8wOFzSbADUxY0zEx09z7kMDGVcFHF-mNA9puR3_nIHNDPVtXdUgbsJMPGf_7h9Y44lDjMNERpvYWttQNtMU0eItdN3cQqIVg3eB7eE1eNNBFfPPQD8n3z6eXJ-vs_Nvqy8nH88wKJUSmGJRSVmWOKpdSaRQWa8bqXGlb8ZKXgAo5oLTLBqUoy0rmNi9Y3iQHkEQdkvf73DH4nzPGyfQu7s6BAf0cDVdaMF2Ucod-2KM2PRwDNmYMroewNZyZnX6T9Jt7_Yl99xA7Vz3WT-Sj7wQc74Fb1-H2_0nm62r9GJntN1yc8O5pA8IPk27U0lxdrMzFap1fnalPZiX-Ad7Womk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1673074857</pqid></control><display><type>article</type><title>Transarterial chemoembolization aggravated peritumoral fibrosis via hypoxia-inducible factor-1α dependent pathway in hepatocellular carcinoma</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Qu, Kai ; Yan, Zhaoyong ; Wu, Yousheng ; Chen, Yibing ; Qu, Ping ; Xu, Xinsen ; Yuan, Peng ; Huang, Xiaojun ; Xing, Jinliang ; Zhang, Hongxin ; Liu, Chang ; Zhang, Jing</creator><creatorcontrib>Qu, Kai ; Yan, Zhaoyong ; Wu, Yousheng ; Chen, Yibing ; Qu, Ping ; Xu, Xinsen ; Yuan, Peng ; Huang, Xiaojun ; Xing, Jinliang ; Zhang, Hongxin ; Liu, Chang ; Zhang, Jing</creatorcontrib><description>Background and Aim It was commonly accepted that chemotherapeutic cytotoxicity was the main cause for hepatic failure in hepatocellular carcinoma patients after repeated transarterial chemoembolization (TACE). However, the effect of embolization‐induced hypoxia on liver cirrhosis has rarely been concerned. Methods Serum levels of alanine aminotransferase, aspartate aminotransferase, and albumin were used to detect liver injury. Hepatic artery ligation was performed in carbon tetrachloride‐induced rat hepatic fibrosis model to mimic the effect of hepatic hypoxia on liver fibrosis after TACE. Sirius Red staining and immunohistochemical analysis of alpha‐smooth muscle actin (α‐SMA) were used to detect the activation of hepatic stellate cells. Moreover, the expression of hypoxia and fibrosis‐related molecules were analyzed at protein and/or mRNA level. Results Patients showed a significant increase in alanine aminotransferase and aspartate aminotransferase (P = 0.006), accompanied by a decrease in albumin (P = 0.005) after repeated TACE. Hepatic artery ligation significantly promoted carbon tetrachloride‐induced rat liver fibrosis progression as indicated by Sirius Red and α‐SMA staining, as well as increased expression of hypoxia‐inducible factor (HIF)‐1α, transforming growth factor (TGF)‐β1, and vascular endothelial growth factor (VEGF). Conditioned media of hypoxia‐treated L02 cells induced the expression of Collagen I and α‐SMA in LX‐2 cells, which was inhibited by HIF‐1α small interfering RNA. Finally, HIF‐1α inhibitor LW6 attenuated the hypoxia‐induced fibrosis progression in vivo. Conclusion Our data demonstrate that TACE‐induced hepatic hypoxia aggravates the fibrosis progression in peritumoral liver tissue, thus leads to the deterioration of liver function. Intervention of HIF‐1α might be a valuable strategy to optimize the efficacy and reduce the complication of TACE.</description><identifier>ISSN: 0815-9319</identifier><identifier>EISSN: 1440-1746</identifier><identifier>DOI: 10.1111/jgh.12873</identifier><identifier>PMID: 25641377</identifier><language>eng</language><publisher>Australia: Blackwell Publishing Ltd</publisher><subject>Adult ; Aged ; Animals ; Carcinoma, Hepatocellular - drug therapy ; Carcinoma, Hepatocellular - pathology ; Cell Hypoxia ; Chemoembolization, Therapeutic - adverse effects ; Disease Models, Animal ; Disease Progression ; Epirubicin - administration &amp; dosage ; Epirubicin - adverse effects ; Female ; Fibrosis ; Fluorouracil - administration &amp; dosage ; Fluorouracil - adverse effects ; hepatocellular carcinoma ; Humans ; hypoxia ; Hypoxia-Inducible Factor 1, alpha Subunit - physiology ; Infusions, Intra-Arterial ; Liver - pathology ; Liver Cirrhosis, Experimental ; liver fibrosis ; Liver Neoplasms - drug therapy ; Liver Neoplasms - pathology ; Male ; Middle Aged ; Organoplatinum Compounds - administration &amp; dosage ; Organoplatinum Compounds - adverse effects ; Rats, Sprague-Dawley ; transarterial chemoembolization</subject><ispartof>Journal of gastroenterology and hepatology, 2015-05, Vol.30 (5), p.925-932</ispartof><rights>2014 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd</rights><rights>2014 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3633-60a855b82e625567e3ced00d267cb1818ae6e1ae5c9fe5388b52c2402f000a873</citedby><cites>FETCH-LOGICAL-c3633-60a855b82e625567e3ced00d267cb1818ae6e1ae5c9fe5388b52c2402f000a873</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fjgh.12873$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fjgh.12873$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25641377$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Qu, Kai</creatorcontrib><creatorcontrib>Yan, Zhaoyong</creatorcontrib><creatorcontrib>Wu, Yousheng</creatorcontrib><creatorcontrib>Chen, Yibing</creatorcontrib><creatorcontrib>Qu, Ping</creatorcontrib><creatorcontrib>Xu, Xinsen</creatorcontrib><creatorcontrib>Yuan, Peng</creatorcontrib><creatorcontrib>Huang, Xiaojun</creatorcontrib><creatorcontrib>Xing, Jinliang</creatorcontrib><creatorcontrib>Zhang, Hongxin</creatorcontrib><creatorcontrib>Liu, Chang</creatorcontrib><creatorcontrib>Zhang, Jing</creatorcontrib><title>Transarterial chemoembolization aggravated peritumoral fibrosis via hypoxia-inducible factor-1α dependent pathway in hepatocellular carcinoma</title><title>Journal of gastroenterology and hepatology</title><addtitle>J Gastroenterol Hepatol</addtitle><description>Background and Aim It was commonly accepted that chemotherapeutic cytotoxicity was the main cause for hepatic failure in hepatocellular carcinoma patients after repeated transarterial chemoembolization (TACE). However, the effect of embolization‐induced hypoxia on liver cirrhosis has rarely been concerned. Methods Serum levels of alanine aminotransferase, aspartate aminotransferase, and albumin were used to detect liver injury. Hepatic artery ligation was performed in carbon tetrachloride‐induced rat hepatic fibrosis model to mimic the effect of hepatic hypoxia on liver fibrosis after TACE. Sirius Red staining and immunohistochemical analysis of alpha‐smooth muscle actin (α‐SMA) were used to detect the activation of hepatic stellate cells. Moreover, the expression of hypoxia and fibrosis‐related molecules were analyzed at protein and/or mRNA level. Results Patients showed a significant increase in alanine aminotransferase and aspartate aminotransferase (P = 0.006), accompanied by a decrease in albumin (P = 0.005) after repeated TACE. Hepatic artery ligation significantly promoted carbon tetrachloride‐induced rat liver fibrosis progression as indicated by Sirius Red and α‐SMA staining, as well as increased expression of hypoxia‐inducible factor (HIF)‐1α, transforming growth factor (TGF)‐β1, and vascular endothelial growth factor (VEGF). Conditioned media of hypoxia‐treated L02 cells induced the expression of Collagen I and α‐SMA in LX‐2 cells, which was inhibited by HIF‐1α small interfering RNA. Finally, HIF‐1α inhibitor LW6 attenuated the hypoxia‐induced fibrosis progression in vivo. Conclusion Our data demonstrate that TACE‐induced hepatic hypoxia aggravates the fibrosis progression in peritumoral liver tissue, thus leads to the deterioration of liver function. Intervention of HIF‐1α might be a valuable strategy to optimize the efficacy and reduce the complication of TACE.</description><subject>Adult</subject><subject>Aged</subject><subject>Animals</subject><subject>Carcinoma, Hepatocellular - drug therapy</subject><subject>Carcinoma, Hepatocellular - pathology</subject><subject>Cell Hypoxia</subject><subject>Chemoembolization, Therapeutic - adverse effects</subject><subject>Disease Models, Animal</subject><subject>Disease Progression</subject><subject>Epirubicin - administration &amp; dosage</subject><subject>Epirubicin - adverse effects</subject><subject>Female</subject><subject>Fibrosis</subject><subject>Fluorouracil - administration &amp; dosage</subject><subject>Fluorouracil - adverse effects</subject><subject>hepatocellular carcinoma</subject><subject>Humans</subject><subject>hypoxia</subject><subject>Hypoxia-Inducible Factor 1, alpha Subunit - physiology</subject><subject>Infusions, Intra-Arterial</subject><subject>Liver - pathology</subject><subject>Liver Cirrhosis, Experimental</subject><subject>liver fibrosis</subject><subject>Liver Neoplasms - drug therapy</subject><subject>Liver Neoplasms - pathology</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Organoplatinum Compounds - administration &amp; dosage</subject><subject>Organoplatinum Compounds - adverse effects</subject><subject>Rats, Sprague-Dawley</subject><subject>transarterial chemoembolization</subject><issn>0815-9319</issn><issn>1440-1746</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kMFu1DAQhi0EokvhwAsgH-GQ1o5jO3uEquxCq3Ip6tGaOJONSxIHO2m7PATvwovwTHi7bW_MZTTSN79mPkLecnbEUx1fb9ojnpdaPCMLXhQs47pQz8mClVxmS8GXB-RVjNeMsYJp-ZIc5FIVXGi9IL8vAwwRwoTBQUdti73HvvKd-wWT8wOFzSbADUxY0zEx09z7kMDGVcFHF-mNA9puR3_nIHNDPVtXdUgbsJMPGf_7h9Y44lDjMNERpvYWttQNtMU0eItdN3cQqIVg3eB7eE1eNNBFfPPQD8n3z6eXJ-vs_Nvqy8nH88wKJUSmGJRSVmWOKpdSaRQWa8bqXGlb8ZKXgAo5oLTLBqUoy0rmNi9Y3iQHkEQdkvf73DH4nzPGyfQu7s6BAf0cDVdaMF2Ucod-2KM2PRwDNmYMroewNZyZnX6T9Jt7_Yl99xA7Vz3WT-Sj7wQc74Fb1-H2_0nm62r9GJntN1yc8O5pA8IPk27U0lxdrMzFap1fnalPZiX-Ad7Womk</recordid><startdate>201505</startdate><enddate>201505</enddate><creator>Qu, Kai</creator><creator>Yan, Zhaoyong</creator><creator>Wu, Yousheng</creator><creator>Chen, Yibing</creator><creator>Qu, Ping</creator><creator>Xu, Xinsen</creator><creator>Yuan, Peng</creator><creator>Huang, Xiaojun</creator><creator>Xing, Jinliang</creator><creator>Zhang, Hongxin</creator><creator>Liu, Chang</creator><creator>Zhang, Jing</creator><general>Blackwell Publishing Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201505</creationdate><title>Transarterial chemoembolization aggravated peritumoral fibrosis via hypoxia-inducible factor-1α dependent pathway in hepatocellular carcinoma</title><author>Qu, Kai ; Yan, Zhaoyong ; Wu, Yousheng ; Chen, Yibing ; Qu, Ping ; Xu, Xinsen ; Yuan, Peng ; Huang, Xiaojun ; Xing, Jinliang ; Zhang, Hongxin ; Liu, Chang ; Zhang, Jing</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3633-60a855b82e625567e3ced00d267cb1818ae6e1ae5c9fe5388b52c2402f000a873</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Animals</topic><topic>Carcinoma, Hepatocellular - drug therapy</topic><topic>Carcinoma, Hepatocellular - pathology</topic><topic>Cell Hypoxia</topic><topic>Chemoembolization, Therapeutic - adverse effects</topic><topic>Disease Models, Animal</topic><topic>Disease Progression</topic><topic>Epirubicin - administration &amp; dosage</topic><topic>Epirubicin - adverse effects</topic><topic>Female</topic><topic>Fibrosis</topic><topic>Fluorouracil - administration &amp; dosage</topic><topic>Fluorouracil - adverse effects</topic><topic>hepatocellular carcinoma</topic><topic>Humans</topic><topic>hypoxia</topic><topic>Hypoxia-Inducible Factor 1, alpha Subunit - physiology</topic><topic>Infusions, Intra-Arterial</topic><topic>Liver - pathology</topic><topic>Liver Cirrhosis, Experimental</topic><topic>liver fibrosis</topic><topic>Liver Neoplasms - drug therapy</topic><topic>Liver Neoplasms - pathology</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Organoplatinum Compounds - administration &amp; dosage</topic><topic>Organoplatinum Compounds - adverse effects</topic><topic>Rats, Sprague-Dawley</topic><topic>transarterial chemoembolization</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Qu, Kai</creatorcontrib><creatorcontrib>Yan, Zhaoyong</creatorcontrib><creatorcontrib>Wu, Yousheng</creatorcontrib><creatorcontrib>Chen, Yibing</creatorcontrib><creatorcontrib>Qu, Ping</creatorcontrib><creatorcontrib>Xu, Xinsen</creatorcontrib><creatorcontrib>Yuan, Peng</creatorcontrib><creatorcontrib>Huang, Xiaojun</creatorcontrib><creatorcontrib>Xing, Jinliang</creatorcontrib><creatorcontrib>Zhang, Hongxin</creatorcontrib><creatorcontrib>Liu, Chang</creatorcontrib><creatorcontrib>Zhang, Jing</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of gastroenterology and hepatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Qu, Kai</au><au>Yan, Zhaoyong</au><au>Wu, Yousheng</au><au>Chen, Yibing</au><au>Qu, Ping</au><au>Xu, Xinsen</au><au>Yuan, Peng</au><au>Huang, Xiaojun</au><au>Xing, Jinliang</au><au>Zhang, Hongxin</au><au>Liu, Chang</au><au>Zhang, Jing</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Transarterial chemoembolization aggravated peritumoral fibrosis via hypoxia-inducible factor-1α dependent pathway in hepatocellular carcinoma</atitle><jtitle>Journal of gastroenterology and hepatology</jtitle><addtitle>J Gastroenterol Hepatol</addtitle><date>2015-05</date><risdate>2015</risdate><volume>30</volume><issue>5</issue><spage>925</spage><epage>932</epage><pages>925-932</pages><issn>0815-9319</issn><eissn>1440-1746</eissn><abstract>Background and Aim It was commonly accepted that chemotherapeutic cytotoxicity was the main cause for hepatic failure in hepatocellular carcinoma patients after repeated transarterial chemoembolization (TACE). However, the effect of embolization‐induced hypoxia on liver cirrhosis has rarely been concerned. Methods Serum levels of alanine aminotransferase, aspartate aminotransferase, and albumin were used to detect liver injury. Hepatic artery ligation was performed in carbon tetrachloride‐induced rat hepatic fibrosis model to mimic the effect of hepatic hypoxia on liver fibrosis after TACE. Sirius Red staining and immunohistochemical analysis of alpha‐smooth muscle actin (α‐SMA) were used to detect the activation of hepatic stellate cells. Moreover, the expression of hypoxia and fibrosis‐related molecules were analyzed at protein and/or mRNA level. Results Patients showed a significant increase in alanine aminotransferase and aspartate aminotransferase (P = 0.006), accompanied by a decrease in albumin (P = 0.005) after repeated TACE. Hepatic artery ligation significantly promoted carbon tetrachloride‐induced rat liver fibrosis progression as indicated by Sirius Red and α‐SMA staining, as well as increased expression of hypoxia‐inducible factor (HIF)‐1α, transforming growth factor (TGF)‐β1, and vascular endothelial growth factor (VEGF). Conditioned media of hypoxia‐treated L02 cells induced the expression of Collagen I and α‐SMA in LX‐2 cells, which was inhibited by HIF‐1α small interfering RNA. Finally, HIF‐1α inhibitor LW6 attenuated the hypoxia‐induced fibrosis progression in vivo. Conclusion Our data demonstrate that TACE‐induced hepatic hypoxia aggravates the fibrosis progression in peritumoral liver tissue, thus leads to the deterioration of liver function. Intervention of HIF‐1α might be a valuable strategy to optimize the efficacy and reduce the complication of TACE.</abstract><cop>Australia</cop><pub>Blackwell Publishing Ltd</pub><pmid>25641377</pmid><doi>10.1111/jgh.12873</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0815-9319
ispartof Journal of gastroenterology and hepatology, 2015-05, Vol.30 (5), p.925-932
issn 0815-9319
1440-1746
language eng
recordid cdi_proquest_miscellaneous_1673074857
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Adult
Aged
Animals
Carcinoma, Hepatocellular - drug therapy
Carcinoma, Hepatocellular - pathology
Cell Hypoxia
Chemoembolization, Therapeutic - adverse effects
Disease Models, Animal
Disease Progression
Epirubicin - administration & dosage
Epirubicin - adverse effects
Female
Fibrosis
Fluorouracil - administration & dosage
Fluorouracil - adverse effects
hepatocellular carcinoma
Humans
hypoxia
Hypoxia-Inducible Factor 1, alpha Subunit - physiology
Infusions, Intra-Arterial
Liver - pathology
Liver Cirrhosis, Experimental
liver fibrosis
Liver Neoplasms - drug therapy
Liver Neoplasms - pathology
Male
Middle Aged
Organoplatinum Compounds - administration & dosage
Organoplatinum Compounds - adverse effects
Rats, Sprague-Dawley
transarterial chemoembolization
title Transarterial chemoembolization aggravated peritumoral fibrosis via hypoxia-inducible factor-1α dependent pathway in hepatocellular carcinoma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T06%3A29%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Transarterial%20chemoembolization%20aggravated%20peritumoral%20fibrosis%20via%20hypoxia-inducible%20factor-1%CE%B1%20dependent%20pathway%20in%20hepatocellular%20carcinoma&rft.jtitle=Journal%20of%20gastroenterology%20and%20hepatology&rft.au=Qu,%20Kai&rft.date=2015-05&rft.volume=30&rft.issue=5&rft.spage=925&rft.epage=932&rft.pages=925-932&rft.issn=0815-9319&rft.eissn=1440-1746&rft_id=info:doi/10.1111/jgh.12873&rft_dat=%3Cproquest_cross%3E1673074857%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1673074857&rft_id=info:pmid/25641377&rfr_iscdi=true